[Clinical studies with cefoperazone in the biliary disease]
- PMID: 3989972
[Clinical studies with cefoperazone in the biliary disease]
Abstract
The concentration of cefoperazone (CPZ) in serum and bile was estimated after intravenous drip infusion of 1 g of the drug in 11 patients, who have performed cholecystectomy, choledocholithotomy and T-tube drainage for gallstone diseases. Administration of cefazolin (CEZ) 1 g was compared by the cross over method. After 1 g intravenous drip infusion of CPZ, the mean serum concentration was 88.3 +/- 24 micrograms/ml at 1 hour, 52 +/- 11.7 micrograms/ml at 2 hours and 36.5 +/- 10 micrograms/ml at 4 hours. The maintenance period of serum concentration was inclined to be longer in CPZ than in CEZ. After 1 g intravenous drip infusion of CPZ, the mean bile concentration reached to 810 +/- 459 micrograms/ml in 2 hours and it was maintained as high as 562 +/- 319 micrograms/ml even after 4 hours. On the other hand, after 1 g intravenous drip infusion of CEZ, the mean bile concentration was only 28.7 +/- 26 micrograms/ml in 1 hour and was low level in the progress. As compared with the highest concentration of CPZ and CEZ in same patient, the mean bile concentration of CPZ (942 +/- 525 micrograms/ml) was about 30 times higher than that of CEZ (28.6 +/- 26.3 micrograms/ml). There was no difference in the group of Gram-positive cocci between minimum inhibitory concentration (MIC) of CPZ and that of CEZ. While MIC of CEZ in the group of Gram-negative bacilli was from 0.78 to over 400 micrograms/ml, MIC of CPZ in that group was from 0.10 to 50 micrograms/ml. The value in CPZ was lower than that in CEZ at all strains. No side effects was seen in all patients.
Similar articles
-
Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.J Antibiot (Tokyo). 1986 May;39(5):699-712. doi: 10.7164/antibiotics.39.699. J Antibiot (Tokyo). 1986. PMID: 3733519
-
[Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].Jpn J Antibiot. 1984 Dec;37(12):2457-77. Jpn J Antibiot. 1984. PMID: 6098740 Japanese.
-
[Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].Jpn J Antibiot. 1984 Dec;37(12):2427-56. Jpn J Antibiot. 1984. PMID: 6098739 Japanese.
-
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].Jpn J Antibiot. 1984 Oct;37(10):1831-45. Jpn J Antibiot. 1984. PMID: 6094863 Japanese.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials